Cargando…
Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures
Melanoma is a highly aggressive skin cancer, which, although highly immunogenic, frequently escapes the body’s immune defences. Immune checkpoint inhibitors (ICI), such as anti-PD1, anti-PDL1, and anti-CTLA4 antibodies lead to reactivation of immune pathways, promoting rejection of melanoma. However...
Autores principales: | Hossain, Sultana Mehbuba, Gimenez, Gregory, Stockwell, Peter A., Tsai, Peter, Print, Cristin G., Rys, Janusz, Cybulska-Stopa, Bozena, Ratajska, Magda, Harazin-Lechowska, Agnieszka, Almomani, Suzan, Jackson, Christopher, Chatterjee, Aniruddha, Eccles, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554309/ https://www.ncbi.nlm.nih.gov/pubmed/36248850 http://dx.doi.org/10.3389/fimmu.2022.955063 |
Ejemplares similares
-
Differential Expression of BARD1 Isoforms in Melanoma
por: McDougall, Lorissa I., et al.
Publicado: (2021) -
Co-Expression of Multiple PAX Genes in Renal Cell Carcinoma (RCC) and Correlation of High PAX Expression with Favorable Clinical Outcome in RCC Patients
por: Li, Lei, et al.
Publicado: (2023) -
Protocol for generating high-quality genome-scale DNA methylation sequencing data from human cancer biospecimens
por: Rodger, Euan J., et al.
Publicado: (2023) -
Can Immune Suppression and Epigenome Regulation in Placenta Offer Novel Insights into Cancer Immune Evasion and Immunotherapy Resistance?
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2021) -
Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2023)